Skip to content

Schizophrenia

ISSN 2754-6993

3 papers in the library · 7 citations · publishing 2022-2025

Papers

Association between formal thought disorder and cannabis use: a systematic review and meta-analysis

Schizophrenia September 29, 2022 Mathilde Argote, Guillaume Sescousse, Jérôme Brunelin et al. 7 citations

Formal thought disorder (FTD) is a multidimensional syndrome occurring along the psychosis continuum. A meta-analysis of 19 studies including 1840 cannabis users and 3351 non-cannabis users found that cannabis users had higher severity of FTD (standardized mean difference = 0.21). This increase was present regardless of disorder severity: in healthy individuals, patients with first-episode psychosis, and patients with schizophrenia. Between-group differences were not significant. Cannabis use appears to be associated with increased FTD severity all along the psychosis continuum, consistent with its known effect on positive symptoms.

Experiences of felt presence in first episode psychosis.

Schizophrenia November 26, 2025 Ben Alderson Day, Peter Moseley, Angela Woods et al.

Felt presence—the sensation that someone else is nearby despite no sensory evidence—has been recognized in psychosis for over a century but has been difficult to study. Recently it has been identified across multiple diagnoses and emphasized by people with psychosis as a clinical priority. This work describes how felt presence appears in a first-episode psychosis sample and reports initial links to affect, gender, and psychopathology.

Automated Detection of Psychedelic-Induced Head-Twitch Response in Mice

Schizophrenia January 1, 2023 Alaina M. Jaster, Javier González-Maeso

The head-twitch response (HTR) in rodents is a behavioral marker of serotonin 2A receptor activation caused by psychedelics. This work describes a method using a magnetic ear tag reporter with automated quantification and biphasic detection to measure HTR in mice given the psychedelic DOI. The approach can help study molecular mechanisms of psychosis and identify signaling processes relevant to antipsychotic and psychedelic compounds.